News Daily News Mobile Health for Cardiac Rehab Doesn’t Aid Older Adults With CVD: RESILIENT Caitlin E. Cox January 15, 2025
News Daily News Patient Experience Worsens When Private Equity Firms Acquire US Hospitals Todd Neale January 10, 2025
News Daily News Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe Caitlin E. Cox January 09, 2025
News Daily News Radial Artery Best for Secondary Access During TAVI: PULSE Registry Michael O'Riordan December 23, 2024
News Opinion Conversations in Cardiology All Eyes on PCI—Should Patients’ Family Members Watch Cases? December 19, 2024
News Daily News Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting Caitlin E. Cox December 17, 2024
News Daily News In 2025, CMS Final Rule Will Bring ‘Death by a Thousand Cuts’ to Cardiologists Yael L. Maxwell December 09, 2024
News Daily News Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3 Todd Neale December 09, 2024
News Daily News Smokeless Oral Nicotine: Many Unknowns, Potential Risks to CV Health Caitlin E. Cox December 06, 2024
News Conference News PCR London Valves 2024 Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI Michael O'Riordan December 02, 2024
News Features Once Burned, Twice Shy, Cardiologists Ditch X for Bluesky Yael L. Maxwell November 29, 2024
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News AHA 2024 ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH Caitlin E. Cox November 18, 2024
News Conference News AHA 2024 Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY Shelley Wood November 17, 2024
News Conference News TCT 2024 QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe Caitlin E. Cox October 30, 2024
News Conference News TCT 2024 Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows Michael O'Riordan October 29, 2024
Presentation TCT 2024 TCT 844: Symptom-Associated Comorbidities Negatively Affect Symptom Improvement and Event Free Survival After TAVI Presenter: Constantijn Venema October 29, 2024
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024